Table 4.

Number of drugs per PWAD and polypharmacy. Median (1^st-3^rd quartile); Differences in regard to age group, living situation, sex, and symptom onset

		Median number of drugs received	p-value (MWU)	Proportion of polypharmacy (≥5 drugs)	p-value (CHI2)
Total sample	N=191	4 (2-6)		n=95; 50%
Age
<65 years	n=38; 20%	3 (2-5)	0.011*	n=13; 34%	0.032*
≥65 years	n=153; 80%	5 (3-7)		n=82; 54%
Living Situation
HC	n=88; 46%	4 (2-6)	0.001*	n=32; 36%	0.001*
LTC	n=103; 54%	5 (4-7)		n=63; 61%
Sex
female	n=106; 56%	5 (2-6)	0.480	n=57; 54%	0.213
male	n=85; 44%	4 (2-6)		n=38; 45%
Dementia onset
YOD	n=93; 49%	4 (2-6)	0.068	n=42; 45%	0.218
LOD	n=98; 51%	5 (3-7)		n=53; 54%

CHI2 chi square test, HC home care, LTC long term care, LOD late onset dementia, MWU Mann-Whitney-U test, YOD young onset dementia, * difference statistically significant